{{Rsnum
|rsid=883924
|Chromosome=9
|position=90419249
|Orientation=plus
|GMAF=0.3343
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=RP11-389K14.3
|Gene_s=RP11-389K14.3
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 3.1 | 32.3 | 64.6
| HCB | 0.0 | 33.3 | 66.7
| JPT | 2.3 | 34.1 | 63.6
| YRI | 42.3 | 52.1 | 5.6
| ASW | 37.5 | 46.4 | 16.1
| CHB | 0.0 | 33.3 | 66.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 43.9 | 51.4 | 4.7
| MEX | 0.0 | 0.0 | 0.0
| MKK | 40.3 | 47.7 | 12.1
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22841784
  |Trait=Hepatitis C induced liver fibrosis
  |Title=Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.
  |RiskAllele=A
  |Pval=2E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}